|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1077887 |
USP |
Bromperidol Decanoate 15 mg |
|
1,344.00 CHF
1,411.20 €
|
|
|
|
USP-1078008 |
USP |
Brompheniramine Maleate 125 mg |
|
385.33 CHF
404.60 €
|
|
|
|
USP-1078201 |
USP |
Budesonide 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1078245 |
USP |
Budesonide Related Compound E - (16aIpha,17 -[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4, 14-triene-3,20-dione) 25 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1078267 |
USP |
Budesonide Related Compound G - (16alpha,17-[butylidenebis(oxy)]-11beta, 21-dihydroxypregna-4-ene-3,20-dione) 25 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1078289 |
USP |
Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) 25 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1078303 |
USP |
Bumetanide 125 mg |
|
460.00 CHF
483.00 €
|
|
|
|
USP-1078325 |
USP |
Bumetanide Related Compound A - 3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid 10 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1078336 |
USP |
Bumetanide Related Compound B - 3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid 25 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1078507 |
USP |
Bupivacaine Hydrochloride ((±)-1-Butyl-2',6'-pipecoloxylidide monohydrochloride, monohydrate) 300 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1078518 |
USP |
Bupivacaine Related Compound A - 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide 50 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1078529 |
USP |
Bupivacaine Related Compound B - (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 50 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1078573 |
USP |
Buspirone Related Compound A (75 mg x 2) - (2-(Piperazin-1-yl)pyrimidine) 2 x 75 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1078642 |
USP |
Buspirone Related Compound K (50 mg) - (8-azaspiro[4.5]decane-7,9-dione) 50 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1078697 |
USP |
Buprenorphine Related Compound B CII ((S)-2-(4,5alpha-Epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl)-3,3-dimethylbutan-2-ol hydrochloride) (CONTROLLED IN USA) 25 mg |
|
1,944.00 CHF
2,041.20 €
|
|
|
|
USP-1078700 |
USP |
Buprenorphine Hydrochloride CIII (21-Cyclopropyl-7alpha -[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine hydrochloride) (CONTROLLED IN GERMANY) 50 mg |
|
841.60 CHF
883.68 €
|
|
|
|
USP-1078711 |
USP |
Buprenorphine Related Compound A - ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]-3,3-dimethylbutan-2-ol) CII (CONTROLLED IN USA) 25 mg |
|
1,940.80 CHF
2,037.84 €
|
|
|
|
USP-1078722 |
USP |
Buprenorphine System Suitability Mixture CII (50 mg) (Mixture of Buprenorphine and about 0.5% of Ethenobuprenorphine) (CONTROLLED IN GERMANY) 50 mg |
|
2,003.20 CHF
2,103.36 €
|
|
|
|
USP-1078733 |
USP |
Bupropion Hydrochloride 200 mg |
|
630.67 CHF
662.20 €
|
|
|
|
USP-1078744 |
USP |
Bupropion Hydrochloride (HCl) Related Compound A - 2-(tert-butylamino)-4'-chloropropiophenone hydrochloride 15 mg |
|
1,586.67 CHF
1,666.00 €
|
|
|
|
USP-1078755 |
USP |
Bupropion Hydrochloride (HCl) Related Compound B - 2-(tert-butylamino)-3'-bromopropiophenone hydrochloride 10 mg |
|
1,586.67 CHF
1,666.00 €
|
|
|
|
USP-1078766 |
USP |
Bupropion Hydrochloride (HCl) Related Compound C - 1-(3-chlorophenyl)-2-hydroxy-1-propanone (COLD SHIPMENT REQUIRED) 40 mg |
|
1,882.67 CHF
1,976.80 €
|
|
|
|
USP-1078799 |
USP |
Bupropion Hydrochloride Related Compound F - 1-(3-chlorophenyl)-1-hydroxypropan-2-one (COLD SHIPMENT REQUIRED) 40 mg |
|
1,710.67 CHF
1,796.20 €
|
|
|
|
USP-1078802 |
USP |
Buspirone Hydrochloride 200 mg |
|
482.67 CHF
506.80 €
|
|
|
|
USP-1078813 |
USP |
Buspirone Related Compound G (50 mg) - (1,4-Di(pyrimidin-2-yl)piperazine) 50 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1078824 |
USP |
Buspirone Related Compound L - (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione) 2 x 75 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1078835 |
USP |
Buspirone Related Compound N (50 mg) - (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione) 50 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1078846 |
USP |
Bupropion Hydrobromide 200 mg |
|
497.33 CHF
522.20 €
|
|
|
|
USP-1078857 |
USP |
Bupropion Related Compound G (2-Bromo-1-(3-chlorophenyl)propan-1-one) 50 mg |
|
1,586.67 CHF
1,666.00 €
|
|
|
|
USP-1079000 |
USP |
Butabarbital CIII (5-sec-Butyl-5-ethylbarbituric acid) (CONTROLLED IN GERMANY) 200 mg |
|
579.20 CHF
608.16 €
|
|
|
|
USP-1081002 |
USP |
Butalbital CIII (200 mg) (CONTROLLED IN GERMANY) 200 mg |
|
841.60 CHF
883.68 €
|
|
|
|
USP-1081501 |
USP |
Butamben 200 mg |
|
476.00 CHF
499.80 €
|
|
|
|
USP-1081750 |
USP |
1,4-Butanedisulfonic Acid 120 mg |
|
968.00 CHF
1,016.40 €
|
|
|
|
USP-1081807 |
USP |
1-Butanol 3 x 1,2 mL |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1081829 |
USP |
2-Butanol 3 x 1,2 mL |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1081842 |
USP |
2,3-Butanedithiol 3 x 1 g |
|
228.00 CHF
239.40 €
|
|
|
|
USP-1082300 |
USP |
Butoconazole Nitrate 200 mg |
|
445.33 CHF
467.60 €
|
|
|
|
USP-1082504 |
USP |
Butorphanol Tartrate CIV (CONTROLLED IN USA) 350 mg |
|
956.80 CHF
1,004.64 €
|
|
|
|
USP-1082592 |
USP |
Butyl Anthranilate (Butyl 2-Aminobenzoate) (List chemical) 1 mL |
|
361.33 CHF
379.40 €
|
|
|
|
USP-1082606 |
USP |
Butyl Acetate 3 x 1,2 mL |
|
465.33 CHF
488.60 €
|
|
|
|
USP-1082617 |
USP |
Butyl Cinnamate 500 mg |
|
228.00 CHF
239.40 €
|
|
|
|
USP-1082628 |
USP |
Butyl Heptanoate (5 x 0.5 mL) 5 x 0,5 mL |
|
228.00 CHF
239.40 €
|
|
|
|
USP-1082639 |
USP |
Butyl Stearate 500 mg |
|
234.67 CHF
246.40 €
|
|
|
|
USP-1082672 |
USP |
Butyl Valerate 1 ml |
|
228.00 CHF
239.40 €
|
|
|
|
USP-1082708 |
USP |
Butylated Hydroxytoluene 500 mg |
|
533.33 CHF
560.00 €
|
|
|
|
USP-1082901 |
USP |
Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate 25 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1082956 |
USP |
Butane-1,3-diol 1 mL |
|
512.00 CHF
537.60 €
|
|
|
|
USP-1082967 |
USP |
Butyl Hexanoate 3 x 500 mg |
|
228.00 CHF
239.40 €
|
|
|
|
USP-1083008 |
USP |
2-tert-Butyl-4-hydroxyanisole (3-(1,1-dimethylethyl)-4-methoxyphenol) 200 mg |
|
565.33 CHF
593.60 €
|
|
|
|
USP-1083100 |
USP |
3-tert-Butyl-4-hydroxyanisole 200 mg |
|
533.33 CHF
560.00 €
|
|
